Alicia Calvo-Villamañán
@aliciapcv.bsky.social
440 followers 570 following 61 posts
| CRISPR, Plasmid Biology, Bacterial EcoEvo & AMR | Sci-Illustrator | @embo.org postdoctoral fellow, San-Millán lab @cnb-csic.bsky.social 🇪🇸 Previously: PhD in Bikard Lab, @pasteur.fr 🇫🇷 | She/Her | From 🇪🇸 & 🇵🇹 | 💜
Posts Media Videos Starter Packs
Pinned
Reposted by Alicia Calvo-Villamañán
doudna-lab.bsky.social
New paper online at @nature.com from co-leads @erinedoherty.bsky.social + @benadler.bsky.social !
erinedoherty.bsky.social
Now online at @nature.com we show how the Panoptes defense system protects against viruses that attempt immune evasion - and expands our understanding of the role of oligonucleotides in immunity.

Check out this work co-led with @benadler.bsky.social here:

www.nature.com/articles/s41...
A miniature CRISPR–Cas10 enzyme confers immunity by inhibitory signalling - Nature
Panoptes, an anti-phage defence system against virus-mediated immune suppression, is revealed.
www.nature.com
Reposted by Alicia Calvo-Villamañán
pasteuredu.bsky.social
🔬PPU 2025 Call for Candidates - Discover the PhD projects

Today's featured projects: 4 Cell Biology & Infection projects and 2 Parasites & Insect Vectors projects

🗓 Applications deadline: October 20, 2025
📍Program starts: October 2026

Discover all projects & apply now: bit.ly/4nlPz8x
aliciapcv.bsky.social
Congratulations François!! So well deserved 🥳🥳
Reposted by Alicia Calvo-Villamañán
epcrocha.bsky.social
Very happy to see this one out: doi.org/10.1093/molbev/msaf192
Here, we assessed the contribution of natural transformation to the acquisition of novel genes. See preprint thread. @molbioevol.bsky.social #microsky #evobio
Reposted by Alicia Calvo-Villamañán
cnb-csic.bsky.social
El grupo de Álvaro San Millán revela el coste de mantener la resistencia en enterobacterias

El trabajo traza un mapa funcional del plásmido pOXA-48, con potencial para guiar nuevas terapias contra resistencias

bit.ly/4p0fCmY

@sanmillan.bsky.social @aliciapcv.bsky.social @jorgesastred.bsky.social
Identifican el coste fisiológico de mantener la resistencia microbiana en enterobacterias - CNB
bit.ly
Reposted by Alicia Calvo-Villamañán
natmicrobiol.nature.com
#NatMicroPicks

AI Designs Next-Gen Antibiotics! 💊🤖

Generative deep learning and genetic algorithms created structurally novel antibiotics that effectively target drug-resistant bacteria, offering a powerful new tool to combat drug resistance.

#MicroSky #AMR

www.cell.com/cell/abstrac...
A generative deep learning approach to de novo antibiotic design
A generative AI platform is developed for de novo antibiotic design, yielding lead compounds with selective antibacterial activity, distinct mechanisms of action, and in vivo efficacy against multidru...
www.cell.com
aliciapcv.bsky.social
Thank you Jorge! As always, it was a pleasure working with you 🤩
aliciapcv.bsky.social
Thank you very much Rita 🎉
aliciapcv.bsky.social
Thank you very much David 🥳 A congrats from my PhD supervisor will forever be worth twice the happiness points! 🥲
aliciapcv.bsky.social
Muchas gracias Ana Elena!!! Hay que celebrarlo! 🥳
aliciapcv.bsky.social
Thank you very much Zamin!
aliciapcv.bsky.social
Muito obrigada Filipa! 🥳🥳
aliciapcv.bsky.social
Thank you very much Dave! I am glad you enjoyed it!
aliciapcv.bsky.social
We would like to end by thanking @natcomms.nature.com and the reviewers for their comments that made our original manuscript stronger and more useful to the community. And @cnb-csic.bsky.social for their support. We would also like to thank our colleagues on whose work we build our own!
aliciapcv.bsky.social
Our results also highlight the usefulness of using high-throughput techniques to explore previously unknown biological phenomena at a genetic level, and the need to perform said studies in realistic set-ups such as clinical strains. 14/14
aliciapcv.bsky.social
All in all, our study highlights the role of different plasmid-encoded genes in the biology of pOXA-48 and opens new doors to explore alternative ways to fight AMR in enterobacteria. 13/14
aliciapcv.bsky.social
This opens a gateway to explore new ways to exploit these physiological changes as potential new antimicrobial strategies. 12/14
aliciapcv.bsky.social
Expressing BlaOXA-48 leads to changes in the cell envelope, thus leading to a decrease in the fitness of the cell. This means that carrying plasmids such as pOXA-48 can have downstream repercussions, such as said fitness costs and even collateral sensitivity to other antibiotics. 11/14
Collateral sensitivity associated with antibiotic resistance plasmids
Acquisition of antibiotic resistance plasmids induces collateral sensitivity to clinically relevant antibiotics in Escherichia coli, paving the way for targeted 'anti-plasmid' therapies able to prefer...
elifesciences.org
aliciapcv.bsky.social
In fact, deleting blaOXA-48 from pOXA-48 strongly decreases the cost associated with the plasmid. 10/14